comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Arthrosi therapeutics - Page 1 : comparemela.com
Novel URAT1 Inhibitors Advance for Gout
New treatment options on the horizon come into better focus
Peking
Beijing
China
Japan
Vienna
Wien
Austria
San-diego
California
United-states
Chinese
Japanese
URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi
AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.
Energy-computer-tomography
American-college-of-rheumatology
American-college
Robert-keenan
Arthrosi-therapeutics
Dual-energy-computer-tomography
URAT1 Inhibitor Beats Allopurinol for Treating Gout Arthritis With Tophi
The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout with tophi.
Energy-computer-tomography
Morris
Energy-computed-tomography
American-college-of-rheumatology
American-college
Robert-keenan
Arthrosi-therapeutics
Dual-energy-computer-tomography
Dual-energy-computed-tomography
Sustained Serum Urate Reduction for Gout Patients Observed with AR882
In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.
San-diego
California
United-states
Robertt-keenan
Energy-computer-tomography
American-college-of-rheumatology-convergence
Trial-using-dual-energy-computed-tomography
American-college-of-rheumatology
American-college
Dual-energy-computer-tomography
Arthrosi-therapeutics
Novel Gout Drug Aces Mid-Stage Tests
Mechanism different from currently available therapies
San-diego
California
United-states
Australia
Taiwan
Robert-keenan
John-gever
American-college-of-rheumatology
Arthrosi-therapeutics
American-college
Managing-editor
vimarsana © 2020. All Rights Reserved.